Pharmabiz

Maharashtra FDA cancels Cipla Pharma’s Pune drug sale licences after Bombay HC directed fresh hearing

Maharashtra FDA cancels Cipla Pharma’s Pune drug sale licences after Bombay HC directed fresh hearing: Our Bureau, Mumbai Monday, October 5, 2026, 14:15 Hrs [IST] The Maharashtr ...
Pharmabiz

Addex Therapeutics appoints Jean-Philippe Rocher as head of pharmaceutical development

Addex Therapeutics appoints Jean-Philippe Rocher as head of pharmaceutical development: Geneva, Switzerland Monday, October 5 ...
Pharmabiz

India's next life sciences manufacturing leap will be powered by resilience and innovation: Grant Thornton Bharat-FICCI report

India's next life sciences manufacturing leap will be powered by resilience and innovation: Grant Thornton Bharat-FICCI report: Our Bureau, Mumbai Monday, October 5, 2026, 15:15 H ...
Pharmabiz

Lilavati Hospital and Research Centre launches Auditory Verbal Therapy clinic

Lilavati Hospital and Research Centre has launched a dedicated Auditory Verbal Therapy (AVT) Clinic. The clinic will provide specialised therapy and family centred support to children with hearing ...
Pharmabiz

Eight Global Organisations ink joint declaration in to make diabetic foot a world health priority

Eight organisations from four continents signed a Joint Declaration on Diabetic Foot Survival and Limb Preservation at DFSICON 2026, the 23rd Annual Conference of the Diabetic Foot Society of India ...
Pharmabiz

HCAH and QMS join hands to create India’s largest patient support programme platform

HCAH and QMS join hands to create India’s largest patient support programme platform: Our Bureau, Mumbai Monday, October 5, 2026, 14:45 Hrs [IST] Health Care At Home India Pvt L ...
Pharmabiz

Natco Pharma to increase its investment in eGenesis to US$ 16.70 million

Natco Pharma to increase its investment in eGenesis to US$ 16.70 million: Our Bureau, Mumbai Monday, October 5, 2026, 14:25 Hrs [IST] Natco Pharma Limited has decided to increase ...
Pharmabiz

Aurobindo Pharma receives US FDA final approval for perampanel tablets

Aurobindo Pharma receives US FDA final approval for perampanel tablets: Our Bureau, Mumbai Monday, October 5, 2026, 14:35 Hrs [IST] Aurobindo Pharma Limited announce the receipt o ...
Pharmabiz

Indian healthcare accelerates towards smarter, more connected hospitals

Indian healthcare accelerates towards smarter, more connected hospitals: Nandita Vijayasimha, Bengaluru Monday, October 5, 2026, 13:45 Hrs [IST] India is building the next generat ...
Pharmabiz

US FDA approves Edwards Lifesciences’ AUTUS Size-Adjustable Valve, a surgical pulmonary valve for paediatric patients

US FDA approves Edwards Lifesciences’ AUTUS Size-Adjustable Valve, a surgical pulmonary valve for paediatric patients: Irvine, California Monday, October 5, 2026, 13:00 Hrs [IST ...
Pharmabiz

Indian households shift from reactive treatment to broader care portfolio, reveals Pronto Consult study

Indian households shift from reactive treatment to broader care portfolio, reveals Pronto Consult study: Our Bureau, Chennai Monday, October 5, 2026, 12:15 Hrs [IST] According to ...
Pharmabiz

Pfizer’s Litfulo significantly improved facial and total body repigmentation in patients with nonsegmental vitiligo

Pfizer’s Litfulo significantly improved facial and total body repigmentation in patients with nonsegmental vitiligo: New York Monday, October 5, 2026, 12:00 Hrs [IST] Pfizer Inc ...